The Science 37 Metasite in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial.

A biopharma company was conducting a Phase II randomized controlled trial in the United States for a dermatological condition. The protocol required patients aged 18 or older with mild-to-moderate acne. The sponsor faced challenges with recruiting a diverse and representative patient population as well as study start-up time. Learn how the Science 37 Metasite delivered:

• Accelerated enrollment
• 82% patient retention
• Diversity to meet skin tone requirements